Physician profile
Zachary M Bauman
NPI 1538390026
$367,976.02
in general payments reported to CMS, 2019-2025
14 companies · $52K in 2025
The $52K reported for 2025 was more than what 99% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,288 · 2020: $22K · 2021: $24K · 2022: $115K · 2023: $148K · 2024: $3,564 · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $98K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $64K · Travel and Lodging: $26K · Education: $7,613 · Food and Beverage: $4,817 · Honoraria: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $98,298.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,023.75 |
| Travel and Lodging | $25,987.47 |
| Education | $7,612.84 |
| Food and Beverage | $4,817.06 |
| Honoraria | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $184,748.28 | 2019-2025 | Ribfix Blu Advantage, Advantagerib, Ribfix Titan |
| Smith+Nephew, INC. | $124,142.57 | 2019-2025 | Stravix, Grafix, Grafix Pl |
| Atricure, INC. | $35,166.36 | 2020-2024 | |
| Kls-Martin L.P. | $23,085.62 | 2019-2025 | |
| Davol INC. | $176.14 | 2019-2024 | Phasix Mesh |
| Haemonetics Corporation | $141.23 | 2022 | |
| Innovation Technologies INC | $128.13 | 2022 | |
| Acell, INC. | $117.80 | 2019 | |
| Depuy Synthes Sales INC. | $109.16 | 2021 | |
| Osiris Therapeutics INC. | $60.99 | 2019 | |
| Integra Lifesciences Corporation | $33.69 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $26.73 | 2023 | Exalt Model D |
| Polynovo North America LLC | $23.15 | 2023 | |
| Acumed LLC | $16.17 | 2024 | Ribloc, Biobridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Bauman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.